← Mechanisms of action
HTR2C
SINGLE PROTEINHomo sapiens
Preferred name: Serotonin 2c (5-HT2c) receptor ChEMBL ↗
Linked proteins
Drugs acting on this target (30)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| athx-105 | Agonist | experimental | Small molecule | HTR2C agonist |
| bmb-101 | Agonist | experimental | Small molecule | HTR2C agonist |
| fenfluramine (Pondimin) | Agonist | approved | Small molecule | HTR2C agonist |
| gm-2505 | Agonist | experimental | Small molecule | HTR2C agonist |
| lorcaserin (belviq) | Agonist | approved | Small molecule | HTR2C agonist |
| lp352 | Agonist | experimental | Small molecule | HTR2C agonist |
| ly03020 | Agonist | experimental | Small molecule | HTR2C agonist |
| tak-233 | Agonist | experimental | Small molecule | HTR2C agonist |
| vabicaserin | Agonist | experimental | Small molecule | HTR2C agonist |
| agomelatine (Valdoxan) | Antagonist | experimental | Small molecule | HTR2C antagonist |
| carphenazine (proketazine) | Antagonist | approved | Small molecule | HTR2C antagonist |
| chlorprothixene (taractan) | Antagonist | approved | Small molecule | HTR2C antagonist |
| cyclobenzaprine (flexeril) | Antagonist | approved | Small molecule | HTR2C antagonist |
| eltoprazine | Antagonist | experimental | Small molecule | HTR2C antagonist |
| loxapine (loxitane) | Antagonist | approved | Small molecule | HTR2C antagonist |
| methysergide (sansert) | Antagonist | approved | Small molecule | HTR2C antagonist |
| metixene (trest) | Antagonist | approved | Small molecule | HTR2C antagonist |
| mirtazapine (remeron) | Antagonist | approved | Small molecule | HTR2C antagonist |
| nefazodone (serzone) | Antagonist | approved | Small molecule | HTR2C antagonist |
| olanzapine (zyprexa) | Antagonist | approved | Small molecule | HTR2C antagonist |
| quetiapine (seroquel) | Antagonist | approved | Small molecule | HTR2C antagonist |
| risperidone (risperdal) | Antagonist | approved | Small molecule | HTR2C antagonist |
| tedatioxetine | Antagonist | experimental | Small molecule | HTR2C antagonist |
| thioridazine (mellaril) | Antagonist | approved | Small molecule | HTR2C antagonist |
| trazodone (desyrel) | Antagonist | approved | Small molecule | HTR2C antagonist |
| trifluoperazine (stelazine) | Antagonist | approved | Small molecule | HTR2C antagonist |
| trimipramine (surmontil) | Antagonist | approved | Small molecule | HTR2C antagonist |
| viloxazine (Qelbree) | Antagonist | approved | Small molecule | HTR2C antagonist |
| xc101-d13h | Antagonist | experimental | Small molecule | HTR2C antagonist |
| ziprasidone (geodon) | Antagonist | approved | Small molecule | HTR2C antagonist |